Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tavneos
Pharma
Merck-Kelun, China deal wisdom, Takeda—Fierce Pharma Asia
Merck and Kelun's sac-TMT reported three positive phase 3s. Experts talk useful tools in China dealmaking. Takeda was hit with a pay-for-delay verdict.
Angus Liu
May 22, 2026 8:53am
Tavneos patient starts resume in Japan amid safety scrutiny
May 21, 2026 11:38am
FDA takes first steps in withdrawing approval of Amgen's Tavneos
Apr 28, 2026 11:37am
FDA warns of liver safety concerns linked to Amgen's Tavneos
Mar 31, 2026 4:27pm
With trial data in question, FDA asks Amgen to ground Tavneos
Feb 4, 2026 7:55am
CHMP backs 6 new meds, will probe Amgen's Tavneos
Jan 30, 2026 12:00pm
